In the University of Warwick and King’s College London, the FIELD-LAB of NRG has found its first international partners. Despite the significant barriers created by both the COVID-pandemic and Brexit, researchers and scientists on both sides of the Channel managed to get things started and hope to present exciting new findings in due time. Dr Cinzia Imberti, Sir Henry Wellcome Postdoctoral Fellow, University of Warwick, UK and Nora Klaassen, project manager R&D at Field-Lab, Petten, the Netherlands, shed some light on how this collaboration started and its hopes for the future.

FIELD-LAB is de incubator voor nieuwe nucleaire geneesmiddelen. Samen met partners ontwikkelt FIELD-LAB nieuwe nucleaire geneesmiddelen voor gepersonaliseerde behandeling van kankerpatiënten.

De plannen voor FIELD-LAB in Petten nemen steeds vastere vormen aan, en menigeen staat te popelen om een bijdrage aan dit bijzondere initiatief te leveren.

The official launch of FIELD-LAB took place on February 6, 2019 in Petten. A unique collaboration to benefit a wide range of patients.

On the 3rd of February more than 2,6 million people in the Netherlands watch the NOS news at 8 p.m., which features an item on the growing number of cancer patients in the Netherlands